Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
GH · against 92 other Healthcare companies of similar size
Ranked #89 of 93 · scores higher than 2% of peers
Bars: peers in each 10-point band of the profitability score5 peers with a profitability score of 10–19, including GH · Click a bar to see the companies
Mainly because of its return on invested capital, return on assets and operating margin, which are weaker than most Healthcare peers.
| Metric | GH | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 91 reported | -163.9% | 11.4% | 2% | 33% | |
| Operating marginHigher is better · 92 reported | -39.7% | 17.3% | 4% | 33% | |
| Return on assetsHigher is better · 90 reported | -23.7% | 6.3% | 4% | 33% | |
| Return on equityHigher is better · 87 reported | Not reported | 11.9% | — | — | Context only |
| Gross marginHigher is better · 94 reported | 65.0% | 61.4% | 59% | Context only |
A metric that is not reported is left out of the score; the other weights are rescaled.
| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 17.9B USD | 99 | 76 | |
| 1 | 13.9B EUR (≈$15.3B) | 99 | 78 | |
| 1 | 20.0B AUD (≈$13.2B) | 99 | 77 | |
| 4 | 23.8B USD | 98 | 84 | |
| 5 | 193.6B HKD (≈$24.8B) | 97 | 78 | |
| 85 | 14.0B USD | 25 | 31 | |
| 86 | 21.8B USD | 24 | 32 | |
| 87 | 13.7B USD | 22 | 45 | |
| 88 | 16.5B USD | 15 | 37 | |
| 89 | 23.5B USD | 14 | 27 | |
| 89 | 22.8B USD | 14 | 38 | |
| 89 | 41.6B USD | 14 | 34 | |
| 92 | 14.5B USD | 10 | 30 | |
| 93 | 26.0B USD | 6 | 28 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score